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Abstract:
            In-hospital cardiac arrest remains a major problem but new technologies allowing fully
automatic external defibrillation are available. These technologies allow the concept of “external
therapeutic monitoring” of lethal arrhythmias. Since early defibrillation improves outcome by
decreasing morbidity and mortality, the use of this device should improve the outcome of in-
hospital cardiac arrest victims. Furthermore, the use of these devices could allow safe monitoring
and treatment of patients at risk of cardiac arrest who not necessarily must be in conventional
monitoring units (Intensive or Coronary Care Units) saving costs with a more meaningful use of
resources. The capability to provide early defibrillation within any patient-care areas should be
considered as an obligation (“standard of care”) of the modern hospital.
Key words:  cardiac arrest, cost-effective, defibrillation, ventricular arrhythmias, ventricular
fibrillation and ventricular tachycardia.
Introduction
            Cardiovascular disease is the major cause of death in the majority of countries1,2. In
developed countries (e.g. United States), nearly the half of these deaths are unexpected and
sudden3,4. Although the broad majority of sudden cardiac deaths occur outside the hospital and
very poor survival rates have been reported, in-hospital cardiac arrest remains a major problem.
The aim of this article is to review the actual knowledge of the utility of “fully automatic”
external defibrillators for treatment of in-hospital cardiac arrest. The name “automated” external
defibrillator (AED) must be distinguished from fully “automatic” external defibrillator. The
automatic device is able to deliver a shock without intervention from an operator whereas the
automated device only “advises” by a voice or a text to deliver the energy. Thus, the automated
device requires operator intervention.
Physiological considerations of cardiac arrest
            Cardiopulmonary resuscitation maneuvers can sustain a patient for a certain time but is
unlikely to restore an organized rhythm of the heart. To achieve this goal defibrillation and
advanced cardiovascular care are necessary, which must be administered in the shortest possible
interval after the arrhythmic event. Furthermore, the risk of ischemia and the defibrillation
threshold increase with arrhythmia duration5. The time to defibrillation is the single most
important   determinant   of   survival   from   cardiac   arrest6,7,8,9,10,11,12,13,14,15,16,17.   In  addition,
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ventricular fibrillation (VF) tends to evolve to asystole within few minutes18,19,20,21,22,23,24,25,26,27.
Thus, survival rates after VF decrease approximately 7% to 10% with every minute that
defibrillation is delayed18,19,20,21,22,23,24. In addition, the cerebral cortex is irreversibly damaged if
cardiac arrest is not quickly interrupted18,28,29,30. Because of these facts, individual physicians as
well as the American Heart Association, the American College of Emergency Physicians, the
European Resuscitation Council and others have advocated the widespread dissemination of
defibrillators for decreasing mortality and morbidity for victims of cardiac arrest31,32,33,34. 
In-hospital cardiac arrest
The classical reality
            Sustained ventricular tachycardia (VT) and VF, even in hospitalized patients, are major
causes of morbidity and mortality28,35,36,37. In the best setting (monitoring wards), continuous
ECG monitoring allows identification of lethal arrhythmias and alarm systems alert nursing and
medical staff. However, a time delay between the arrhythmic event and human intervention
obviously exists. This time delay may be prolonged in certain circumstances even in monitoring
wards. In addition, response time  intervals  for  in-hospital resuscitation  events  are often
inaccurate and must be corrected before documented times to defibrillation can be considered
reliable34. 
            Although major evidence exists supporting the need for rapid defibrillation and important
advances in out-of-hospital cardiac arrest treatment have been achieved (e.g. out-of hospital
cardiac arrest quick response programs)15,16,34,38,39,40,41,42,43, in-hospital cardiac arrest is still a
major problem without significant advances (e.g. changing strategies) during the last 30 years.
This leads to important mortality, morbidity and social as well as economic costs28,35,36,37. The
scarcity of data28,44 related to deployment of AEDs in hospitals and its impact on patient outcome
reflects the very limited existence of in-hospital early defibrillation programs. 
            However, as stated in major guidelines, early defibrillation is a high-priority goal in out-
of hospital as well as in-hospital cardiac arrest31,32,33,34. Clearly the earlier defibrillation occurs,
the better the prognosis in adults and children18,19,20,21,23,24,25,27,45,46,47. 
            The capability to provide early defibrillation within any patient-care areas should be
considered as an obligation (“standard of care”) of the modern hospital. Furthermore, cardiac
arrests often occur outside monitored areas. Recently, Herlitz et al.28 reported that out of 557
patients suffering in-hospital cardiac arrest, only 292 patients (53%) were in monitored wards
and from those only 43.2% of the patients could be discharged alive. They reported that the
median interval between collapse and first defibrillation was 1 minute in monitored wards and 5
minutes in non-monitored wards. Only 31% of patients from non-monitored wards could be
discharged alive and with a cerebral performance inferior to that of survivors of monitored
wards. Other authors48 present similar data showing better in-hospital survival for witnessed
arrest (25%) than for non-witnessed arrest (7%) but, in addition, they report a disproportionately
high incidence of non-witnessed arrests during the night (12AM to 6 AM) resulting in a very
poor survival rate (0%). Cardiac arrest occurs in 4.8% of hospitalized patients because of acute
myocardial infarction49. The survival rate to hospital discharge for these individuals was 29.4%
49. Although ventricular tachycardia or fibrillation was documented in 34.7% of patients, only
47.5% of those survived to discharge49. Thus, the use of “automatic” defibrillators had probably
improved outcome of those patients presenting in-hospital cardiac arrest. Furthermore, although
survival to hospital discharge offers an objective evaluation point and is used in the broad
majority of reports, several patients who survive a cardiac arrest present neurological damage,
which   is   highly  dependent   of   the   response   time   to   cardiac   arrest18,28,29.   Therefore,   the
neurological   status   should   also   be   considered   when   reporting   results   of   resuscitation
procedures30.
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The new reality
            Very early response to lethal ventricular tachyarrhythmias is achievable now with fully
“automatic” external defibrillators. As occurs with implantable cardioverter defibrillators, these
devices may be individually programmed to intervene. Thus, as occurs with other medical
management strategies (e.g. drugs prescription), physicians may and should decide under which
circumstances and how the device will react in presence of arrhythmias. 
            In a multicenter European trial, Martínez-Rubio et al.50 tested the safety and efficacy of
an automatic external cardioverter-defibrillator [Powerheart®; Cardiac Science Inc., Irvine
(California, USA)]. Subjects (n=117) included patients undergoing electrophysiologic testing
(n=66; all with suspected/documented VT/VF or undergoing implantation of implantable
cardioverter defibrillator) as well as patients in monitoring wards (n=51) at risk of cardiac arrest. 
Patients with active implanted cardioverter-defibrillators were excluded from the study. 
            The automatic external cardioverter-defibrillator was connected to patients using self-
adhesive electrodes.  Placement of the electrodes (either antero-posterior or sternal-apex) was at
the discretion of the investigators.  
            The automatic external defibrillator was used for monitoring and treatment of patients in
the coronary care units or intensive care units.  It was also used as a “rescue” defibrillator during
ICD implantations. This device operates either in “advisory” or in “automatic” mode.   In
advisory mode, it will detect the arrhythmia, alarm, charge the capacitors, and prompt the user to
deliver the shock. The energy (maximum of 360J monophasic) and time delay (10s to 600s) for
each shock could be programmed (up to 9 shocks per episode).   Shock delivery was non-
committed such that therapy is automatically aborted should the rhythm spontaneously convert to
a non-shockable rhythm.   In addition, the device algorithm featured a modulation domain
function which allows to discriminate between ventricular and supraventricular rhythms.
            The performance of the device in detecting shockable and non-shockable rhythms was
confirmed by review of the simultaneously recorded Holter data and the programmed parameters.
A total of 1,240 hours of monitoring and 1,988 episodes of rhythm changes were documented. 
The device detected ventricular arrhythmias with a sensitivity of 100% and specificity of 97.6%. 
The mean response time to shock was 14.4 seconds [evaluated in those episodes (sustained) that
were associated with a full capacitor charge cycle].  All false positives were caused by T-wave
oversensing during ventricular pacing.  There were no complications or adverse events. There
were a total of 35 sustained arrhythmic episodes treated by the device (12 in the EP lab and 23 in
monitoring wards).  All 35 episodes were successfully (100% efficacy) converted to normal sinus
rhythm with a first shock success of 94.3% (Figure 1).  This European study50 confirms the
initial experience presented by Mattioni et al51 in a multicenter American trail. These authors
reported a sensitivity and specificity of 100% and 99.4%, respectively, and a response time of 22
seconds51. 
            Although some differences exist (e.g. sample size, hours of monitoring, software version,
etc.) both studies50,51 lead to the same conclusions. Thus, both groups (European and American)
of investigators agree that the device is safe and highly effective in monitoring, detecting and
treating spontaneous rhythms. Therefore, with its wide use a significant improvement in the
treatment of in-hospital cardiac arrest should be expected. In addition, the now available version
of the described automated external cardioverter-defibrillator has important improvements
(compatibility to commercially available patient monitoring systems, biphasic wave forms, etc.).
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Figure 1. 
Upper panel: Recording of the automatic external cardioverter-defibrillator response
to spontaneous monomorphic ventricular tachycardia. The device is programmed to
detect the arrhythmia, to charge and to delay 1 minute the shock delivery. After 24
seconds and spontaneously, the tachycardia terminates. Observe that the device aborts
the shock delivery.  The first circle indicates de beginning of charge (200 J) of the
device. The second circle indicates the full charge of the device (“ready to shock”).
Each line corresponds to 15 seconds of continuous ECG registration. 
Lower panel: Recording of the automatic external cardioverter-defibrillator response
to spontaneous ventricular fibrillation in a patient with admitted because of recurrent
syncope. The first circle indicates de beginning of charge (200 J) of the device. The
second circle indicates the full charge of the device. Note that the device terminates the
arrhythmia when applies the shock. Each line corresponds to 15 seconds of continuous
ECG registration.
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